Manufacturers Life Insurance Company, The Centessa Pharmaceuticals PLC Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 317,329 shares of CNTA stock, worth $5.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
317,329
Previous 264,969
19.76%
Holding current value
$5.38 Million
Previous $4.24 Million
25.47%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$339 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$169 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$164 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$108 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$98.5 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...